Compare Danaher Corporation (DHR) vs KB Financial Group, Inc. (KB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs KB Financial Group, Inc. — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while KB Financial Group, Inc. trades at $123.07 (market cap $42.62B). The key difference: Danaher Corporation is far larger — about 3.6× KB Financial Group, Inc.'s market cap, and KB Financial Group, Inc. pays the higher dividend (2.71%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and KB Financial Group, Inc. for 33 Days on average.
| DHR | KB | |
|---|---|---|
Market Cap | $152.87B | $42.62B |
Volume | 5,228,698 | 164,291 |
Sector | Health | Financials |
52-Week High | $242.05 | $132.88 |
52-Week Low | $161.91 | $77.50 |
Typical Hold Time | 69 Days | 33 Days |
Enterprise Value | $175.08B | $215.53T |
Dividend Yield | 0.74% | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
KB Financial Group (KB) trades at $122.04, down 2.16% today, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 9.68, P/B of 0.94, and consistent earnings beats in recent quarters. Revenue grew from $17.77T in 2022 to $21.23T in 2025, with net income rising to $5.83T. Operating cash flow improved significantly to $4.23T in 2025, while analyst consensus shows 33% buy ratings amid positive momentum coverage.
KB presents a value opportunity with attractive valuation metrics and solid profitability, though technical indicators suggest near-term consolidation. Key risks include market volatility and execution challenges in non-banking expansion. The stock's current price near support levels and strong institutional interest support a cautiously optimistic outlook for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About KB Financial Group, Inc.
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →
